JC

Joy Cherakkala Paulose

Active Director Director DIN 09388786
DIN 09388786 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Joy Cherakkala Paulose

Data last updated:

Joy Cherakkala Paulose is a Director at Exor Meditec Private Limited (since 2021). The company operates in Healthcare.

DIN 09388786
Primary Designation Director
Industry Healthcare
First Appointment 05 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exor Meditec Private Limited U33100KL2021PTC072059
Director05 Nov 20212021Active

Board colleagues of Joy Cherakkala Paulose

Directorship timeline

Open interactive timeline →
Exor Meditec Private Limited
Premium access

Shareholding and investment profile for Joy Cherakkala Paulose

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Joy Cherakkala Paulose

Joy Cherakkala Paulose currently holds 1 directorship: Exor Meditec Private Limited (Director, since 05 Nov 2021).

Joy Cherakkala Paulose was first appointed on 05 Nov 2021 as Director at Exor Meditec Private Limited.

The current boards of Joy Cherakkala Paulose's companies include Eldo Mani (Exor Meditec Private Limited), Job Kappilumanthadathil Paul (Exor Meditec Private Limited), Paulose Kuriakose (Exor Meditec Private Limited), Prince Puthenpurackal Thomas (Exor Meditec Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available